Close Menu

GPCR screening

The companies will use their respective technologies to discover novel modulators of G-protein coupled receptors and ion channel targets.

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to spend up to $5.5 million in the next fiscal year to fund research and a center to develop technologies to characterize the function of proteins, with the aim of expanding the number of known proteins in the human genome that m

NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

Molecular Devices will also sell ChanTest's cell optimization services to Molecular Devices' customers worldwide using its PatchXpress 7000A, IonWorks Quattro, IonWorks Barracuda, and FLIPR Tetra systems.

The company's partnership with France's Functional Genomics Institute will use French government funding to develop new technology for identifying potential GPCR-related drugs.

The Australian company will use its GPCR-HIT platform to help Takeda Cambridge study potential drug candidate compounds.

The companies will co-promote BioTek's automated sample processor and multi-mode microplate reader with Enzo's calcium assay kit for monitoring intracellular calcium mobilization.

DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.